Limitations, agreements, and source contact

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease · Source last updated 2019-07-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

other Details

Institution/Investigator will not publish without Sponsor prior review and approval.

pi Sponsor Employee

false

restriction Type

OTHER

restrictive Agreement

true

point Of Contact

email

mjuretic@pcyc.com

organization

Pharmacyclics LLC, An AbbVie Company

phone

(408) 215.3628

title

Manuela Juretic, Associate Director, Clinical Operations

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice